Search

everythinglearnresearchcommunity

for

Search:↓

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

CD44 variant changes start alopecia areata, but don't maintain it.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

CD98hc's role in skin health decreases with age.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Alopecia areata involves specific immune cells, offering potential treatment targets.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The role of γδT-cells in causing alopecia areata remains unclear.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Certain NK cell changes in blood may indicate alopecia areata progression.

B cells can both help and hinder the body's defense against melanoma.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.